TNFSF11 and neoplasm: Tumor cells colonized in bone can induce expression of a protein called receptor activator of nuclear factor kappa-Β ligand (RANKL), and an orally administered RANKL inhibitor is a promising therapeutic strategy for treating bone metastasis.